Announcements Trials
Browse Landscape

Phase

Phase 2 13Phase 1 7Phase 3 3Phase NA 1Phase 4 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 6OTHER 3NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Rectal Neoplasms 2Neoplasms 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Anemia 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Smoking Cessation 1Papillomavirus Infections 1Pancreatic Neoplasms 1Pain 1Neutropenia 1Neurotoxicity Syndromes 1Neoplasm Metastasis 1Multiple Endocrine Neoplasia Type 1 1Melanoma 1Lymphoma 1Hypothyroidism 1Human Papillomavirus-Related Cervical Carcinoma 1Hepatitis C, Chronic 1Hepatitis C 1Gastrointestinal Stromal Tumors 1Gallbladder Neoplasms 1Fibrosis 1Fatigue 1Esophageal Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Diabetes Mellitus 1

Interventions

Oxaliplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × NIH × Gastrointestinal Stromal Tumors × Clear all
NCT00274885 2011-12-05

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

National Cancer Institute (NCI)

Phase 4 Unknown
58 enrolled
GastrointestinalSarcoma

Anus Neoplasms, Appendiceal Neoplasms, Bile Duct Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Neurotoxicity Syndromes, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡